Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

republicworld.com - Nitin Waghela - How Pharma Stocks Reacted To Trump's 200% Tariff Threat On Generic Drugs
How Pharma Stocks Reacted To Trump's 200% Tariff Threat On Generic Drugs
Republic World

The shares of Indian pharmaceutical companies plummeted in early trade on Wednesday, July 22, after the US President Donald Trump, announced a phased tariff imposition plan linked to generic drugs. The Nifty Pharma fell nearly 2% in trade on…

swissinfo.ch - swissinfo.ch - Swiss pharma firm Sandoz takes note of proposed US tariffs on generic drugs
Swiss pharma firm Sandoz takes note of proposed US tariffs on generic drugs
www.swissinfo.ch

“At this stage, it is too early to assess the potential implications, as further details on the implementation and scope of this measure are still required”, particularly regarding the group's geographical presence and its…

indianexpress.com - Ravi Dutta Mishra - Trump's tariff threat on generic drugs: Why this matters for Indian pharma companies
Trump's tariff threat on generic drugs: Why this matters for Indian pharma companies
The Indian Express

4 min read New Delhi Make us preferred source on Google US President Donald Trump on Tuesday (July 21) said that tariffs on generic drugs in the US will be raised 100% after two years and to 200% thereafter to “reshore” generic pharma…

thehindu.com - N. Ravi Kumar - Trump's 200% generic tariff threat would imperil Americans: Indian pharma
Trump's 200% generic tariff threat would imperil Americans: Indian pharma
The Hindu

U.S. President Donald Trump has given generic pharmaceutical companies a two-year window to establish manufacturing facilities in the United States, warning that products imported after August 2028 could face tariffs of up to 200%. The…

zerohedge.com - Tyler Durden - UBS Warns Trump's 100% Generic Drug Tariff Puts Indian Pharma 'On Notice'; Goldman Flags Reshoring Winners
UBS Warns Trump's 100% Generic Drug Tariff Puts Indian Pharma 'On Notice'; Goldman Flags Reshoring Winners
Zero Hedge

President Trump will impose a 100% tariff on imported generic drugs starting in August 2028, rising to 200% a year later, unless manufacturers shift production to the US. 'This is done in order to RESHORE Generic Pharmaceutical Production into…

thehindubusinessline.com - Pharma stocks decline; Aurobindo Pharma down over 4%
Pharma stocks decline; Aurobindo Pharma down over 4%
BusinessLine

Pharma stocks declined on Wednesday, with Aurobindo Pharma tumbling over 4 per cent, after US President Donald Trump announced steep tariffs on imported generic medicines from August 2028, asserting that the move was aimed at onshoring the…

indianexpress.com - Anonna Dutt - Indian pharma sees little immediate threat in Trump's 200% tariff plan
Indian pharma sees little immediate threat in Trump's 200% tariff plan
The Indian Express

While the Indian generic pharmaceutical industry so far remained unscathed during several rounds of US tariff announcements, US President Donal Trump on Wednesday in a Truth Social post said tariffs on economical generics from India will be raised…

thehindubusinessline.com - Markets in pressure at midday; banking, IT, pharma drag; auto bucks trend
Markets in pressure at midday; banking, IT, pharma drag; auto bucks trend
BusinessLine

Markets remained under significant pressure through Wednesday's midday session, with the Sensex and Nifty sliding sharply as selling intensified across banking, information technology, and pharmaceutical stocks. As of 12.50 pm, the Sensex was…

dynamitenews.com - Ayushi Bisht - Stock Market Today: Why Are Sensex And Nifty Falling? Pharma Tariffs, Rising Oil Weigh | Dynamite News
Stock Market Today: Why Are Sensex And Nifty Falling? Pharma Tariffs, Rising Oil Weigh | Dynamite News
News: Today's News Headlines & Daily Updates from Sports, Movies, Politics, Business | Dynamite News

Post Published By: Ayushi Bisht Updated: 22 July 2026, 10:20 AM IST Mumbai: Indian benchmark indices extended their losses during early trade on Wednesday, with selling pressure spreading across pharmaceutical, banking, information technology and…

thehindubusinessline.com - Nifty opens lower; pharma stocks bleed, auto sector shines
Nifty opens lower; pharma stocks bleed, auto sector shines
BusinessLine

Benchmarks opened in the red on Wednesday morning, weighed down by rising crude oil prices and geopolitical tensions, even as selective buying in automobile stocks provided some support. The Sensex, which closed at 77,470.11 on Tuesday, opened at…

dnaindia.com - Varsha Agarwal - Trump's proposed 200% tariff is a wake-up call, India's bigger pharma risk lies in China, say experts
Trump's proposed 200% tariff is a wake-up call, India's bigger pharma risk lies in China, say experts
DNA India

India reportedly supplies 47% of all generic prescriptions dispensed in the United States, making India the country's largest source of affordable generic medicines. With US President Donald Trump proposing tariffs of up to 200% on generic drug…

thehindubusinessline.com - US tariff threat drags Nifty Pharma 1.4% lower; Lupin, Auropharma lead decline
US tariff threat drags Nifty Pharma 1.4% lower; Lupin, Auropharma lead decline
BusinessLine

Pharma stocks fell sharply on Wednesday after the US proposed steep tariffs on generic drug imports, with the Nifty Pharma Index dropping 374 points, or 1.43 per cent, to 25,718 by afternoon trade. Only two of the index's 20 constituents ended in…

marketbeat.com - Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap Up - Still a Buy?
Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap Up - Still a Buy?
MarketBeat

Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG - Get Free Report) gapped up prior to trading on Wednesday. The stock had previously closed at $18.37, but opened at $19.31. Ascentage Pharma Group International shares last traded…

thehindubusinessline.com - Team BL - Stock Market Today Live, July 22: Pharma stocks will be in focus today after Trump's tariff announcement
Stock Market Today Live, July 22: Pharma stocks will be in focus today after Trump's tariff announcement
BusinessLine

Sensex Today, Nifty 50 | Stock Market Live Updates - Find here all the live updates related to Sensex, Nifty, BSE, NSE, share prices and Indian stock markets for 22nd July 2026. The US President, Donald Trump, announced that drugs imported into the…

thehindubusinessline.com - Why these 8 stocks including Pharma majors will remain in focus on today following Trump's tariff announcement
Why these 8 stocks including Pharma majors will remain in focus on today following Trump's tariff announcement
BusinessLine

The US President, Donald Trump, announced that drugs imported into the United States will not be charged any tariff for two years. Following this,100% tariff will be levied for one year period and 200% later. In a post on Truth Social, Trump said…

Receive a Daily briefing on Pharma Industry News

Get Started